Michael B. Cook, Ph.D.


Metabolic Epidemiology Branch


9609 Medical Center Drive
Room SG/6E430
Rockville, MD 20850



Research Topics

Dr. Cook’s research interests include the epidemiology of esophageal adenocarcinoma—specifically, sex differences and the effects of obesity in the natural history of this disease—as well as hormonal and genetic mechanisms of prostate carcinogenesis.


Dr. Michael B. Cook earned his B.Sc. in genetics at the University of Nottingham, England in 2003, and a Ph.D. in epidemiology at the University of Leeds, England in 2006. Dr. Cook joined the Hormonal and Reproductive Epidemiology Branch as a visiting postdoctoral fellow in 2007, became a research fellow in 2008, and was promoted to tenure-track investigator in 2011. He was awarded the 2008 Division of Cancer Epidemiology and Genetics (DCEG) Fellowship Achievement Award for Research Excellence, a 2008 NCI Director’s Innovation Award, the DCEG Molecular Epidemiology Course Award for novel research proposals, and the 2013 DCEG Mentoring Award. Dr. Cook is a strong proponent of high-quality mentorship and he recently completed the NCI Executive Coaching program. Dr. Cook currently serves on the DCEG Repository Committee and the DCEG Genomics and Molecular Analysis Resource Management subcommittee. He is an editorial board member of Cancer Epidemiology, Biomarkers and Prevention and a member of the Barrett’s and Esophageal Adenocarcinoma Consortium (BEACON). Dr. Cook is the current chair of the American College of Epidemiology Publications Committee, having served on the committee since 2011.

Selected Publications

  1. Black A, Pinsky PF, Grubb RL 3rd, Falk RT, Hsing AW, Chu L, Meyer T, Veenstra TD, Xu X, Yu K, Ziegler RG, Brinton LA, Hoover RN, Cook MB. Sex steroid hormone metabolism in relation to risk of aggressive prostate cancer. Cancer Epidemiol Biomarkers Prev. 2014;23(11):2374-82.

  2. Cook MB, Wood SN, Cash BD, Young P, Acosta RD, Falk RT, Pfeiffer RM, Hu N, Su H, Wang L, Wang C, Gherman B, Giffen C, Dykes C, Turcotte V, Caron P, Guillemette C, Dawsey SM, Abnet CC, Hyland PL, Taylor PR. Association between circulating levels of sex steroid hormones and Barrett's esophagus in men: a case-control analysis. Clin Gastroenterol Hepatol. 2015;13(4):673-82.

  3. Zhou CK, Pfeiffer RM, Cleary SD, Hoffman HJ, Levine PH, Chu LW, Hsing AW, Cook MB. Relationship between male pattern baldness and the risk of aggressive prostate cancer: an analysis of the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. J Clin Oncol. 2015;33(5):419-25.

  4. Drahos J, Schwameis K, Orzolek LD, Hao H, Birner P, Taylor PR, Pfeiffer RM, Schoppmann SF, Cook MB. MicroRNA Profiles of Barrett's Esophagus and Esophageal Adenocarcinoma: Differences in Glandular Non-native Epithelium. Cancer Epidemiol Biomarkers Prev. 2016;25(3):429-37.

  5. Cook MB, Wang Z, Yeboah ED, Tettey Y, Biritwum RB, Adjei AA, Tay E, Truelove A, Niwa S, Chung CC, Chokkalingam AP, Chu LW, Yeager M, Hutchinson A, Yu K, Rand KA, Haiman CA, African Ancestry Prostate Cancer GWAS Consortium., Hoover RN, Hsing AW, Chanock SJ. A genome-wide association study of prostate cancer in West African men. Hum Genet. 2014;133(5):509-21.

This page was last updated on December 14th, 2016